CloudMD Software & Services Inc. (CVE:DOC – Get Rating) – Equities research analysts at Echelon Wealth Partners issued their Q1 2022 earnings per share estimates for shares of CloudMD Software & Services in a report released on Wednesday, May 4th. Echelon Wealth Partners analyst R. Goff anticipates that the company will earn ($0.02) per share for the quarter. Echelon Wealth Partners has a “Speculative Buy” rating on the stock. Echelon Wealth Partners also issued estimates for CloudMD Software & Services’ Q2 2022 earnings at ($0.02) EPS, Q3 2022 earnings at ($0.02) EPS and Q4 2022 earnings at ($0.01) EPS.
Separately, Canaccord Genuity Group reduced their price target on CloudMD Software & Services from C$3.00 to C$1.50 in a research report on Wednesday.
About CloudMD Software & Services (Get Rating)
CloudMD Software & Services Inc, a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. It offers CloudMD telemedicine application, a telemedicine platform that connects patients to licensed physician through videoconferencing technology; operates a network of inter-connected medical clinics; and Re:Function, an integrated network of 8 rehabilitation clinics that offers various rehabilitation services.
Read More
- World Wresting Entertainment Stock is Hulking Up
- High-Yield Weyco Group Returns To Reasonable Levels
- MarketBeat Podcast: Alternative Investing Strategies Despite Market Volatility
- Limelight Networks Stock is a Speculative Turnaround Opportunity
- The Selloff In SiteOne Landscape Supply Is Overextended
Receive News & Ratings for CloudMD Software & Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CloudMD Software & Services and related companies with MarketBeat.com's FREE daily email newsletter.